← Back
$SERA All transactions

SERA PROGNOSTICS, INC.

▼ SELL

$ Value

$3K

Shares

1,517

Price

$2

Filed

Mar 12

Insider

Name

Boniface John J.

Title

Chief Scientific Officer

CIK

0001870674

Roles

Officer

Transaction Details

Transaction Date

2026-03-11

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

145,842

Footnotes

Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person. | The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $1.90 to $2.30, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade.

Filing Info

Accession No.

0001193125-26-104705

Form Type

4

Issuer CIK

0001534969

Boniface John J.'s History

Date Ticker Type Value
2026-03-11 SERA $3K
2026-03-09 SERA $6K
2025-12-10 SERA $4K
2025-11-10 SERA $20K
2025-09-11 SERA $4K
2025-08-08 SERA $18K
2025-06-10 SERA $2K
2025-05-30 SERA A $5K
2025-05-08 SERA $13K

Other Insiders at SERA (90d)

Insider Bought Sold Last
Lawrence Sandra AJ $3K 2026-03-06
Harrison Robert Gardner
Chief Information Officer
$19K 2026-03-11
Kamdar Kim P. 2026-02-04
Jackson Benjamin
General Counsel
$8K 2026-03-12
Boniface John J.
Chief Scientific Officer
$6K 2026-03-09
Kearney Paul
Chief Data Officer
$7K 2026-03-11
Lindgardt Zhenya
Chief Executive Officer
$49K 2026-03-12
Aerts Austin
Chief Financial Officer
$15K 2026-03-12
Anderson Dyaarl Lee Jr.
Chief Commercial Officer
2026-03-12
Inglis Tiffany Eul Davis
Chief Medical Officer
2026-03-12